July 16, 2020

Fragment-based Drug Discovery-based Products Market, Forecast to 2030

The “Fragment-based Drug Discovery Market: Library and Service Providers, 2020-2030” report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of this approach over the next decade.

Key Inclusions

·        A detailed review of the overall landscape of fragment-based drug discovery library and service providers along with the information on type of product (library and technology), type of service offered (fragment screening and fragment optimization), type of technique used (X-ray crystallography, nuclear magnetic resonance, surface plasmon resonance, and other screening techniques), other services offered (target identification / validation, hit identification, hit-to-lead / lead generation, lead optimization), and end user (industry, academia, and contract research organizations).

·        Elaborate profiles of the companies providing libraries and services for fragment-based drug discovery (shortlisted on the basis of the service portfolio and number of fragment screening techniques offered). Each profile features a brief overview of the company, its financial information (if available), fragment-based library and service portfolio, information on other drug discovery services, recent developments and an informed future outlook.

·        An analysis of the partnerships that have been established in the recent past, covering R&D collaborations, mergers and acquisitions, product development and commercialization agreements, commercialization agreements, distribution and supply agreements, product integration agreements, service agreements, and other relevant types of deals.

·        A detailed analysis on acquisition targets, taking into consideration the historical trend of the activity of the companies that have acquired other firms since 2015, and offering a means for other industry stakeholders to identify potential acquisition targets.

·        An insightful competitiveness analysis of fragment-based drug discovery library and service providers, based on supplier power (based on the years of experience of service provider) and key specifications, such as number of fragment libraries and number of screening techniques.

·        An analysis highlighting the cost saving potential associated with the use of fragment-based drug discovery approach.

·        Informed estimates of the existing market size and the future opportunity for fragment-based drug discovery library and services, over the next decade. Based on multiple parameters, such as annual number of drug discovery projects, outsourcing profile, and adoption of fragment-based drug discovery approach, we have provided informed estimates on the evolution of the market for the period 2020-2030.

For more information, please visit https://www.rootsanalysis.com/reports/view_document/fragment-based-drug-discovery/309.html

The report features the likely distribution of the current and forecasted opportunity across important market segments, mentioned below:

Type of Screening Technique Used

·        X-ray Crystallography

·        Nuclear Magnetic Resonance

·        Surface Plasmon Resonance

·        Other Screening Techniques

Type of Service Offered

·        Library Screening

·        Fragment Screening

·        Fragment Optimization

End User

·        Industry Players

·        Non-Industry Players

Key geographical regions

·        North America (US and Canada)

·        Europe (UK, France, Germany, Spain, Italy, and rest of Europe)

·        Asia-Pacific (China, Japan, India, and rest of Asia-Pacific / rest of the world)

The report also features inputs from eminent industry stakeholders, according to whom the fragment-based approach significantly simplifies the drug discovery process. The report includes detailed transcripts of discussions held with the following experts:

·        Jean-Yves Ortholand (Co-founder and Chief Executive Officer, Edelris)

·        Björn Walse (Chief Executive Officer, SARomics Biostructures)

For more information, please click on the following link:

https://www.rootsanalysis.com/reports/view_document/fragment-based-drug-discovery/309.html

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

Gaurav.Chaudhary@rootsanalysis.com